Edgewise Therapeutics
Price & Volume
Stats
See more52W Range | $10.60-$30.48 |
Market Cap | $2.5B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 9 days ago
Consumer Staples, Real Estate Push US Equity Indexes Higher
Yahoo Finance • 30 days ago
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
Yahoo Finance • 2 months ago
Edgewise Therapeutics Names Michael Nofi New CFO As Michael Carruthers Retires
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
About
CEO | Dr. Kevin Koch Ph.D. |
Address | 1715 38th Street, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
